Drugs / UIC201602
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05190133 | May → Aug 2016 | — | Korea United Pharm. Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05085184 Comparator | Sep → Nov 2021 | hyperlipidemia, combined, 2 | Korea United Pharm. Inc. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UIC201602 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05190133 ↗ |